Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May;98(20):e15718.
doi: 10.1097/MD.0000000000015718.

Top-100 highest-cited original articles in inflammatory bowel disease: A bibliometric analysis

Affiliations

Top-100 highest-cited original articles in inflammatory bowel disease: A bibliometric analysis

Xinrong Chen et al. Medicine (Baltimore). 2019 May.

Abstract

Objectives: The use of citation analysis to identify the first 100 papers in inflammatory bowel disease (IBD) provides unique insights into advances in disease understanding and subsequent follow-up treatment innovations over time.

Methods: The Thomson Reuters Web of Science database with the search terms "inflammatory bowel disease" or "Crohn disease" or "ulcerative colitis" or "colitis" was used to identify all English language full manuscripts for the study. Title, first and senior authors, institution and department of first author, journal, country of origin, year, and topic of each manuscript were analyzed.

Results: The top 100 manuscripts were published between 1955 and 2013. 224,809 eligible papers were returned and the median (range) citation number was 1028.5 (719-3957). The country and year with the greatest number of publications were the USA (n = 47), and 2007 (n = 11). Gastroenterology published the highest number of papers (n = 18, 21,083 citations) and The New England Journal of Medicine had the most citations (n = 13, 25,035 citations).

Conclusions: This highly cited list of papers identifies the subjects and authors who have had the greatest impact on IBD research in the last decades, which serves as a reference for researchers and clinicians "highly citable" manuscripts.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Number of top 100 of publications per year.
Figure 2
Figure 2
Number of top 100 citations per year.
Figure 3
Figure 3
Countries of origin of top 100 papers.

References

    1. Macdonald TT. New cytokine targets in inflammatory bowel disease. Gastroenterol Hepatol 2011;7:474–6. - PMC - PubMed
    1. Silva FA, Rodrigues BL, Ayrizono ML, et al. The immunological basis of inflammatory bowel disease. Gastroenterol Res Pract 2016;2016:2097274. - PMC - PubMed
    1. Burisch J, Munkholm P. Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol 2013;29:357–62. - PubMed
    1. Bernstein CN, Eliakim A, Fedail S, et al. Review Team. World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease: Update August 2015. J Clin Gastroenterol 2016;50:803–18. - PubMed
    1. Lee D, Albenberg L, Compher C, et al. Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology 2015;148:1087–106. - PMC - PubMed

Publication types